Redefining Neuroimaging for Therapeutic Innovation

sBhwf8-unsplash
Close up of 2 people with snowy mountains in the background low sunlight

Redefining Neuroimaging for Faster Decisions

ZRO Imaging (ZRO) makes imaging a strategic advantage, not a bottleneck. Our team includes recognized scientific leaders with hands-on experience in PET and MRI for neurodegenerative diseases, bringing focus, precision, and accountability to every project.

We make imaging a strategic advantage, not a bottleneck. Our team includes recognized scientific leaders with hands-on experience in PET and MRI for neurodegenerative diseases, bringing focus, precision, and accountability to every project.

We work closely with biopharma, diagnostics, and research consortia developing new therapies and biomarkers for neurodegenerative disease.

We don’t just support clinical programs; we move them forward. ZRO stands for more than our name: zero delays, zero unnecessary complexity, and a future with zero neurodegenerative disease.

sharon-pittaway-4_hFxTsmaO4-unsplash

ZRO Delivers End-to-End Imaging CRO Services for Clinical Trials

We help sponsors collect, validate, and interpret imaging data with precision — cutting complexity, minimizing risk, and keeping studies moving.

From first scan to final readout, our focus is simple: make imaging faster, clearer, and built for confident decisions.

End-to-End Imaging Support

zro_illustration-08

01

Imaging Protocol Development and Standardization


Every strong dataset starts with a precise plan.

ZRO designs PET and MRI protocols that connect scientific precision with operational simplicity.

Standardized methods across sites cut variability and eliminate the downstream delays that slow most trials.

zro_illustration-07

02

Site Qualification, Training, and Oversight


Every successful study depends on control and consistency.

ZRO qualifies imaging sites, trains teams on study-specific procedures, and stays closely involved from first scan to final upload.

Real-time QC and direct communication keep data aligned and issues resolved before they affect timelines.

zro_illustration-06

03

Image Management, Reading, and Quantitative Analysis


Once images are acquired, precision handling begins.

All PET and MRI data are stored and processed within validated systems with full traceability.

Each scan undergoes visual QC for quality and protocol compliance, with central reads and quantitative analysis performed when part of the study scope

zro_illustration-05

04

Support for Exploratory and Biomarker-Driven Studies


New PET tracers and exploratory biomarkers demand flexibility.

We design and execute imaging for early-phase and translational programs, integrating PET, MRI, and fluid biomarkers to evaluate tracer behavior, disease mechanisms, and therapeutic effects.

Our scientific guidance and rigorous QC ensure that innovation moves forward without compromising data quality or reliability.

alina-grubnyak-tEVGmMaPFXk-unsplash

What Sets ZRO Apart?

Most imaging CROs focus on execution. ZRO goes further, shaping the imaging strategy, staying close to every detail, and delivering data that meet the highest scientific and operational standards.

Our strength lies in combining scientific depth with operational speed. We anticipate challenges, act quickly, and keep trials moving—so imaging becomes a source of clarity, not unnecessary complexity.

That’s The ZRO Way: expert-led execution, no layers, no friction, and a high-ownership culture that drives projects forward without delay.

Our decentralized model empowers teams to act quickly and decisively. Precision and speed come together naturally in how we work.